Xanthommatin Color Additive for Food Beverage and Drug Compositions
Summary
USPTO published patent application US20260090963A1 by inventor Leila Deravi for xanthommatin as an edible color additive for food, beverage, and drug compositions at 0.01-0.5% wt concentration. The application covers substrates including foods, beverages, drinks, medications, and drug forms.
What changed
The USPTO published patent application US20260090963A1 claiming xanthommatin as an edible color additive for food, beverage, and drug compositions. The invention comprises xanthommatin at a concentration of about 0.01% to 0.5% by weight, optionally combined with dry-based or solution-based carriers, applied to or incorporated into food, beverage, drink, medication, or drug form substrates. The additive can produce colors across the yellow, orange, red, and brown spectrum depending on concentration.
This is a patent application filing only and does not create immediate compliance obligations or regulatory requirements. Manufacturers and developers of food colorants, beverage products, or pharmaceutical formulations may wish to monitor the prosecution of this application to understand potential future intellectual property implications in the natural color additive space.
Archived snapshot
Apr 2, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
Xanthommatin as Color Additive for Food, Beverage and Drug Compositions
Application US20260090963A1 Kind: A1 Apr 02, 2026
Inventors
Leila Deravi
Abstract
A substrate having an edible color additive within the substrate or coated on the substrate is disclosed. The edible color additive comprises xanthommatin at a concentration of about 0.01% wt to about 0.5% wt and optionally a dry based carrier or a solution-based carrier. The substrate is a food, beverage, drink, medication or a drug form. The color additives of the disclosure can be produced in the color spectrum of yellow, orange, red, or concentrated forms (e.g., concentrated yellow appears as brown).
CPC Classifications
A61K 8/29 A61K 8/0245 A61K 8/0275 A61K 8/0283 A61K 8/25 A61K 8/26 A61K 8/411 A61K 8/49 A61K 8/73 A61K 8/8152 A61K 8/85 A61K 8/86 A61Q 17/04 A61Q 19/08 C09B 19/00 C09B 61/00 C09B 67/0097 A61K 2800/412 A61K 2800/438 A61K 2800/45 A61K 2800/52 A61K 2800/651 A61K 2800/654
Filing Date
2025-12-09
Application No.
19414228
Named provisions
Related changes
Get daily alerts for USPTO Patent Applications - Pharma (A61K)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from USPTO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when USPTO Patent Applications - Pharma (A61K) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.